Study#D3252C00001: A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Phase 3 Efficacy and Safety Study Of Benralizumab in Patients with Severe Nasal Polyposis (OSTRO)

Project: Research project

Project Details

StatusFinished
Effective start/end date4/13/18 → 10/13/21

Funding

  • DrugDev Inc. (D3252C00001 // D3252C00001)
  • AstraZeneca Pharmaceuticals LP (D3252C00001 // D3252C00001)